期刊文献+

联合应用自杀基因/前药系统和放疗对人骨肉瘤细胞的杀伤作用 被引量:3

Killing effect of combined application of double suicide gene/prodrug systems and radiotherapy on osteosarcoma cells
原文传递
导出
摘要 目的观察联合应用自杀基因/前药系统和放疗对人骨肉瘤细胞的杀伤作用。方法以大肠杆菌JM107为模板,PCR扩增出CD基因,测序并将其插入真核表达质粒pEGFP-C1中,构建EGFPCD融合基因。用DOTAP将分别含有CD和HSV-TK的两种质粒pEGFP-CD和tgCMVHyTK同时导入人骨肉瘤细胞SAOS-2,经G418和潮霉素B共同筛选后,于荧光显微镜下观察阳性克隆细胞株SAOS-2CDTK。运用PCR和Northernblot方法检测SAOS-2CDTK细胞中的CD和HSV-TK基因及其表达。用MTT法检测单独或联合应用两种前药(GCV、5-FC)对SAOS-2CDTK细胞的存活率、“旁观者效应”以及细胞对放疗敏感性的影响。结果测序图和酶切鉴定证明CD基因的克隆和含EGFPCD融合基因的重组真核表达质粒pEGFP-CD的构建是成功的。荧光显微镜观察SAOS-2CDTK细胞胞质呈现绿色荧光。PCR和Northernblot分析均表明SAOS-2CDTK细胞中含有CD和HSV-TK两个基因,并获得mRNA水平的表达。与单一前药相比,联合应用两种前药时,SAOS-2CDTK细胞的存活率下降,“旁观者效应”及细胞对放疗的敏感性增强。结论联合应用两种自杀基因/前药系统和放疗可增强细胞毒作用,为骨肉瘤的治疗提供了一条新的有效途径。 Objective To investigate the killing effect of combined use of double suicide gene /prodrug system and radiotherapy on o steosarcoma cells.Methods CD gene was amplified from E.Coli JM107by PCR.The PCR product was inse rted into sequencing plasmid pUC19a nd sequenced,then CD gene and eukaryotic expression plasmid p EGFP -C1were ligated to construct th e EGFPCD fusion gene expressed in the same transcription unit with gen e recombinant technology.The positive recombinants were identified by digestion of restriction endonucle ase.The plasmids pEGFP -CD and tgCMVHyTK,carrying CD and HSV -TK gene respectively,were intruduced into osteosarcoma cell SAOS -2by DOTAP.The selected pressure was maintained with G418and Hygromycin B.The positive clone concomitantly expressed two genes was named by SAOS -2CDTK cell.Co-expression of t he EGFPCD and HyTK gene in SAOS -2CDTK cells was detected by PCR and Northern blot.MTT assay was u sed to detect the cytotoxicity,bystander effect and radiosensitivity o f SAOS -2CDTK cells exposed to single a nd double prodrugs.Results Sequencing and restriction endonu-clease digestion proved the success of CD gene clone and construction of r ecombinant eukaryotic expression plasmid pEGFP -CD harboring EGFPCD f usion gene.The green fluorescence c ould be observed in cytoplasm of SAOS -2CDTK cells under fluoresce nce phase-contrast microscopy.Two prominent bands of 594bp CD and395bp HSV -TK fragments were generated in one PCR reaction using DNA from S AOS -2CDTK cells as template.Hybridization of CD and HS V -TK probes with total RNA from SAOS -2CDTK cells showed bands of the expected size,2kb(1.28kb CD +0.7kb EGFP)and 2.09kb(1.03kb HSV -TK +1.06kb Hy )respectively.A combination of GCV a nd 5-FC resulted in 10.2%survival ra te of SAOS -2CDTK that was six-fold less than 9μg GCV(67.4%),seven-fold less than 100μg 5-FC(77.1%).When the mixed(20%SAOS -2CDTK and 80%SAOS -2)cells were exposed to 5-FC,GCV and both prodrugs,the survival rate of SAOS -2cells were 57.6%,10.4%and0respectively.Surviving fraction of SAOS -2CDTK cells treated with GCV and HSV -TK for 24hours prior to irradiation dramatically decreased than single prodrug.Con-clusion Combining suicide gene therapy with radiotherapy could result in enhanced cytotoxicity,thereby provide a new and effective means for treatment of osteosarcoma.[
出处 《中华骨科杂志》 CAS CSCD 北大核心 2002年第7期427-431,共5页 Chinese Journal of Orthopaedics
基金 国家自然科学基金资助项目(39970289)
关键词 骨肉瘤 基因疗法 放射疗法 胞嘧啶 脱氨酶类 胸苷激酶 Osteosarcoma Gene therapy Radiotherapy Cyto-sine Ammonia-lyases Simplexviru s Thymidine kinase
  • 相关文献

参考文献1

二级参考文献1

同被引文献34

  • 1De-HuaWu,LiLiu,Long-HuaChen.Antitumor effects and radiosensitization of cytosine deaminase and thymidine kinase fusion suicide gene on colorectal carcinoma cells[J].World Journal of Gastroenterology,2005,11(20):3051-3055. 被引量:11
  • 2黄圣运,张东升,张世周,刘桂军,赵跃然,王来成,刘义庆.重组表达载体pIRES-CD、pIRES-TK的构建及其在ACC-2细胞中的表达[J].山东大学学报(医学版),2007,45(2):117-123. 被引量:1
  • 3Damron TA,Ward WG,Stewart A.Osteosarcoma,chondrosarcoma,and Ewing's sarcoma.National Cancer Data Base Report.Clin Orthop Relat Res,2007,459:40-47.
  • 4Ham SJ,Schraffordt,Koopsh,et al.Historical,current and future aspects of osteosarcoma treatment.Eur J Surg Oncol,1998,24:584.
  • 5Rosen G,Nirenberq A,Coparros B,et al.Osteogenic sarcoma:eight-percent,three-year survival with combination chemotherapy(T-7).Natl Cancer Inst Monoqr,1981,213-320.
  • 6Rosen G,Nirenberg A.Neoadjuvant chemotherapy for osteogenic sarcoma:a five year follow-up(T-10)and preliminary report of newstudies(T-12).Prog Clin Biol Res,1985,201:39-51.
  • 7Fuchs N,Bielack SS,Epler D,et al.Long-term result of the co-operative German-Austrian-Swiss Osteosarcoma Study Group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs.Ann Oncol,1998,9:893-899.
  • 8Alman BA,DeBari A,Krajbich JI.Massive allografts in the treatment of osteosareoma and Ewing sarcoma in children and adolescents.J Bone Joint Surg.1995.77A:54-64.
  • 9Donati D,Di Liddo M,ZavaRa M,et al.Massive bone allografi reconstruction in High-grade osteosarcoma J.Clin Orthop Relat Res,2000.(377):186-194.
  • 10Mankin HJ,Springfield DS,Gebhardt MC,et al.Current status of allografting for bone tumors.Orthopedics,1992.15:1147-1154.

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部